138 related articles for article (PubMed ID: 9855518)
1. Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody.
Kuwabara S; Asahina M; Koga M; Mori M; Yuki N; Hattori T
Neurology; 1998 Dec; 51(6):1656-60. PubMed ID: 9855518
[TBL] [Abstract][Full Text] [Related]
2. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
3. Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody.
Kuwabara S; Ogawara K; Koga M; Mori M; Hattori T; Yuki N
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):180-4. PubMed ID: 10406985
[TBL] [Abstract][Full Text] [Related]
4. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
5. High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Thomma RCM; Fokke C; Walgaard C; Vermeulen-de Jongh DMC; Tio-Gillen A; van Rijs W; van Doorn PA; Huizinga R; Jacobs BC
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37059469
[TBL] [Abstract][Full Text] [Related]
6. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
7. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
8. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
9. Anti-GM1 IgA antibodies in Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Chen ZW; Cook SD
J Neuroimmunol; 1992 Jan; 36(1):69-76. PubMed ID: 1735770
[TBL] [Abstract][Full Text] [Related]
10. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
[TBL] [Abstract][Full Text] [Related]
11. Axonal involvement at the common entrapment sites in Guillain-Barré syndrome with IgG anti-GM1 antibody.
Kuwabara S; Mori M; Ogawara K; Mizobuchi K; Hattori T; Koga M; Yuki N
Muscle Nerve; 1999 Jul; 22(7):840-5. PubMed ID: 10398200
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibody.
Kuwabara S; Mori M; Ogawara K; Hattori T; Oda S; Koga M; Yuki N
Muscle Nerve; 2001 Jan; 24(1):54-8. PubMed ID: 11150966
[TBL] [Abstract][Full Text] [Related]
13. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
14. Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients.
Deisenhammer F; Keir G; Pfausler B; Thompson EJ
J Neuroimmunol; 1996 May; 66(1-2):85-93. PubMed ID: 8964918
[TBL] [Abstract][Full Text] [Related]
15. Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome.
Koga M; Yuki N; Hirata K; Morimatsu M; Mori M; Kuwabara S
Neurology; 2003 May; 60(9):1514-8. PubMed ID: 12743241
[TBL] [Abstract][Full Text] [Related]
16. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
17. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
18. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
Bech E; Orntoft TF; Andersen LP; Skinhøj P; Jakobsen J
J Neuroimmunol; 1997 Jan; 72(1):59-66. PubMed ID: 9003245
[TBL] [Abstract][Full Text] [Related]
19. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
20. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
